Medifast (MED) Buy Maintained at Imperial Capital Post Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Medifast, Inc. (MED) Tops Q4 EPS by 3c; Guides Q1 Below the Street
March 10, 2014 4:09 PM EDTMedifast, Inc. (NYSE: MED) reported Q4 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $77.3 million versus the consensus estimate of $80.83 million.
Medifast, Inc. sees Q1 2014 EPS of $0.32-$0.35, versus the consensus of $0.49. Medifast, Inc. sees Q1... More
